RU2009105196A - Противовирусные соединения (варианты), фармацевтическая композиция на их основе, названные соединения для изготовления лекарственного средства, способ лечения или профилактики вирусной инфекции с их помощью - Google Patents

Противовирусные соединения (варианты), фармацевтическая композиция на их основе, названные соединения для изготовления лекарственного средства, способ лечения или профилактики вирусной инфекции с их помощью Download PDF

Info

Publication number
RU2009105196A
RU2009105196A RU2009105196/04A RU2009105196A RU2009105196A RU 2009105196 A RU2009105196 A RU 2009105196A RU 2009105196/04 A RU2009105196/04 A RU 2009105196/04A RU 2009105196 A RU2009105196 A RU 2009105196A RU 2009105196 A RU2009105196 A RU 2009105196A
Authority
RU
Russia
Prior art keywords
substituted
carbonylmethyl
methyl
amino
group
Prior art date
Application number
RU2009105196/04A
Other languages
English (en)
Russian (ru)
Inventor
Януш БОТЯНСКИ (HU)
Януш БОТЯНСКИ
Рональд Конрад ГРИФФИТ (US)
Рональд Конрад Гриффит
Сон Мин ПХАМ (US)
Сон Мин ПХАМ
Кристофер Дон РОБЕРТС (US)
Кристофер Дон Робертс
Фрвнц Ульрих ШМИЦ (DE)
Фрвнц Ульрих ШМИЦ
Original Assignee
СмитКлайн Бичэм Конэрейшн (US)
СмитКлайн Бичэм Конэрейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by СмитКлайн Бичэм Конэрейшн (US), СмитКлайн Бичэм Конэрейшн filed Critical СмитКлайн Бичэм Конэрейшн (US)
Publication of RU2009105196A publication Critical patent/RU2009105196A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RU2009105196/04A 2006-07-14 2007-07-12 Противовирусные соединения (варианты), фармацевтическая композиция на их основе, названные соединения для изготовления лекарственного средства, способ лечения или профилактики вирусной инфекции с их помощью RU2009105196A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83104006P 2006-07-14 2006-07-14
US60/831,040 2006-07-14

Publications (1)

Publication Number Publication Date
RU2009105196A true RU2009105196A (ru) 2010-08-27

Family

ID=38742551

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009105196/04A RU2009105196A (ru) 2006-07-14 2007-07-12 Противовирусные соединения (варианты), фармацевтическая композиция на их основе, названные соединения для изготовления лекарственного средства, способ лечения или профилактики вирусной инфекции с их помощью

Country Status (13)

Country Link
EP (1) EP2044083A1 (ko)
JP (1) JP2009543807A (ko)
KR (1) KR20090033881A (ko)
CN (1) CN101490058A (ko)
AR (1) AR062258A1 (ko)
AU (1) AU2007272441A1 (ko)
BR (1) BRPI0714346A2 (ko)
CA (1) CA2657651A1 (ko)
MX (1) MX2009000513A (ko)
PE (1) PE20080427A1 (ko)
RU (1) RU2009105196A (ko)
TW (1) TW200813070A (ko)
WO (2) WO2008008907A2 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9108983B2 (en) 2013-07-23 2015-08-18 Les Laboratoires Servier Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
WO2008137126A2 (en) 2007-05-04 2008-11-13 Vertex Pharmaceuticals Incorporated Combination therapy for the treatment of hcv infection
AR079528A1 (es) 2009-12-18 2012-02-01 Idenix Pharmaceuticals Inc Inhibidores de arileno o heteroarileno 5,5-fusionado del virus de la hepatitis c
EP2655362A1 (en) * 2010-12-22 2013-10-30 Abbvie Inc. Hepatitis c inhibitors and uses thereof
US20120252721A1 (en) * 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
US10080728B2 (en) 2015-01-20 2018-09-25 Viktor Veniaminovich Tets Hemostatic agent
US10167293B2 (en) * 2016-05-26 2019-01-01 Bayer Pharma Aktiengesellschaft [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
CA3064733A1 (en) 2017-05-24 2018-11-29 Viktor Veniaminovich Tets Fractionated antimicrobial compositions and use thereof
US11661431B2 (en) 2021-04-16 2023-05-30 Gilead Sciences, Inc. Thienopyrrole compounds
EP4398989A1 (en) 2021-09-10 2024-07-17 Gilead Sciences, Inc. Thienopyrrole compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0210357A (pt) * 2001-06-11 2004-06-29 Shire Biochem Inc Composto e métodos para o tratamento ou a prevenção de infecções pelo flavivìrus
ZA200509590B (en) * 2003-06-04 2007-04-25 Genelabs Tech Inc Nitrogen-containing heteroaryl derivatives for the treatment of HCV-infection

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9108983B2 (en) 2013-07-23 2015-08-18 Les Laboratoires Servier Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
EA026906B1 (ru) * 2013-07-23 2017-05-31 Ле Лаборатуар Сервье Новые пиррольные соединения, способ их получения и фармацевтические композиции, содержащие их
US10688101B2 (en) 2013-07-23 2020-06-23 Les Laboratories Servier Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
US11058689B2 (en) 2013-07-23 2021-07-13 Les Laboratoires Servier Pyrrole compounds, a process for their preparation and pharmaceutical

Also Published As

Publication number Publication date
AR062258A1 (es) 2008-10-29
MX2009000513A (es) 2009-03-09
PE20080427A1 (es) 2008-06-11
AU2007272441A1 (en) 2008-01-17
EP2044083A1 (en) 2009-04-08
CA2657651A1 (en) 2008-01-17
WO2008008912A1 (en) 2008-01-17
BRPI0714346A2 (pt) 2013-03-19
WO2008008907A3 (en) 2008-03-20
CN101490058A (zh) 2009-07-22
TW200813070A (en) 2008-03-16
AU2007272441A2 (en) 2009-03-19
WO2008008907A2 (en) 2008-01-17
KR20090033881A (ko) 2009-04-06
JP2009543807A (ja) 2009-12-10

Similar Documents

Publication Publication Date Title
RU2009105196A (ru) Противовирусные соединения (варианты), фармацевтическая композиция на их основе, названные соединения для изготовления лекарственного средства, способ лечения или профилактики вирусной инфекции с их помощью
RU2009105837A (ru) Полициклические противовирусные соединения (варианты), фармацевтическая композиция на их основе, способ лечения вирусной инфекции с ее помощью и названные соединения для изготовления лекарственных средств
RU2007130896A (ru) Индольные производные для лечения вирусных инфекций
JP5046942B2 (ja) Ｈｃｖ阻害性の二環式ピリミジン類
CN108200760B (zh) 作为rsv抑制剂的苯并二氮杂䓬衍生物
ES2541660T3 (es) Inhibidores del VHC macrocíclicos sustituidos con pirimidina
ES2456617T3 (es) Inhibidores macrocíclicos del virus de la hepatitis C
TWI383980B (zh) Ｃ型肝炎病毒之大環抑制劑
KR101381176B1 (ko) Ｃ형 간염 바이러스의 마크로사이클릭 억제제
ES2432590T3 (es) Fenilcarbamatos macrocíclicos inhibidores del VHC
JP2019519590A (ja) Ｂ型肝炎ウイルス感染の処置および予防のための新規のジヒドロピロロピリミジン
WO2012037108A1 (en) Aminoquinoline derivatives as antiviral agents
JP2015531772A (ja) 融合二環式スルファモイル誘導体並びにｂ型肝炎の治療のための薬剤としてのその使用
PT1912997E (pt) Inibidores macrocíclicos do vírus da hepatite c
ES2535212T3 (es) Carboxamido-4-[(4-piridil)amino]-pirimidinas para el tratamiento de la hepatitis C
RU2007121505A (ru) Соединения и композиции как ингибиторы протеинкиназы
JP2010521483A5 (ko)
BRPI0614670A2 (pt) inibidores macrocìclicos do vìrus da hepatite c
BRPI0614696A2 (pt) inibidores macrocìclicos de vìrus da hepatite c
CN102869657A (zh) 用于治疗或预防黄病毒感染的类似物
AU2788300A (en) (1,8) naphthyridine derivatives having antiviral activity
ES2954126T3 (es) Derivados del pirazolo[1,5-a]pirimidina-7-amina útiles en terapia
RU2014142328A (ru) Производные пиперидина в качестве агонистов gpr119
JP2013529684A (ja) フラビウイルス感染の処置または予防のための化合物および方法
JP2015508088A (ja) 抗ウイルス化合物

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20110301